Search

everythinglearnresearchcommunity

for

Search:↓

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Balancing testosterone may reduce COVID-19 severity.

COVID-19 can harm male fertility by reducing sperm stem cells and damaging testicular function.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Extracellular vesicles are important for disease treatment and monitoring.

Adipose-derived stem cell exosomes can help reduce skin aging from UV exposure.

Restoring skin bacteria may help reduce hair loss.

Vascular endothelial cells may significantly influence skin stem cells, but more research is needed.

Induced pluripotent stem cells could improve chronic wound healing but face safety and effectiveness challenges.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Restoring microbial balance and using exosome therapies may help treat hair disorders like alopecia and acne.

Yak hair follicles adapt to cold through specific gene regulation, enhancing cell growth.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Post-COVID syndrome symptoms are common and overlap with general health issues.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

iPSC-derived artificial platelets show promise for consistent and effective regenerative therapies.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

ZDHHC17 methylation may help treat or identify facial skin aging.

The drinkable supplement increased hair growth and was safe for women with hair loss.

A machine-learning test using hair can help detect autism early in infants.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Dietary interventions improved hair density and reduced dandruff by balancing scalp microbiota and reducing inflammation.

Platelet-rich plasma might help treat eczema by reducing inflammation and repairing the skin.

BMS-470539 reduces skin fibrosis and inflammation.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.